This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07508/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07508/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07508/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07508/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07508/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07508
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07508 n11:DB07508
dcterms:title
4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE
adms:identifier
n6:99443979 n7:C02 n8:446805 n12:394063 n13:DB07508
n3:IUPAC-Name
n4:271B4B3F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4B45-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4B44-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4B41-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4B42-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4B43-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4B3D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4B3B-363D-11E5-9242-09173F13E4C5 n4:271B4B3E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4B3C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B4B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B4C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4B46-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4B47-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B49-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B48-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B4A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4B51-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B53-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B54-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B50-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B4F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B52-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4B40-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B4D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B4E-363D-11E5-9242-09173F13E4C5